Related Experiment Video
Updated: Jul 15, 2026

Measurement of Heme Synthesis Levels in Mammalian Cells
Published on: July 9, 2015
Ceruloplasmin prevents hemostatic disorders during experimental hyperammonemia
M V Osikov1, E V Makarov, L V Krivokhizhina
1Department of Pathophysiology, Chelyabinsk State Medical Academy. mvo2003@list.ru
Abstract:
Experimental hyperammonemia in rats was accompanied by hemostatic disorders manifesting in coagulopathy (activation of the intrinsic pathway of blood coagulation) and suppression of platelet function. Ceruloplasmin in a total dose of 60 mg/kg effectively normalized coagulation hemostasis and functional activity of platelets by improving secretory processes in platelets and increasing aggregation rate.
Related Concept Videos
Urea Cycle
Hepatic Encephalopathy
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...

